Medicare Enrolled

Dr. Stanley Goldstein, MD

Allergy & Immunology · Rockville Centre, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
242 MERRICK ROAD, Rockville Centre, NY 11570
5165367336
In practice since 2006 (19 years)
NPI: 1548343304 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goldstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goldstein

Dr. Stanley Goldstein is an allergy & immunology specialist in Rockville Centre, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Goldstein performed 6,752 Medicare services across 691 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goldstein received a total of $755,740 from 42 pharmaceutical and/or device companies across 1241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goldstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in NY $755,740 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,752
Medicare services
Top 14% in NY for allergy & immunology
691
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~355 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
2,411 $14 $23
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
2,280 $4 $16
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
675 $11 $51
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
520 $79 $122
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
373 $12 $35
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
266 $23 $120
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
81 $150 $300
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
38 $37 $132
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
27 $9 $50
Influenza vaccine, quadrivalent, 0.5 ml dosage 24 $20 $50
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
22 $36 $40
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
19 $18 $40
Albuterol inhalation solution, 1 mg
A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation.
16 $0 $3
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$755,740
Total received (2018-2024)
Avg $107,963/year across 7 years
Top 2% in NY for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,241
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$694,036 (91.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$56,981 (7.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,723 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$41,715
2023
$88,462
2022
$92,916
2021
$87,434
2020
$43,630
2019
$257,281
2018
$144,301

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$12,876
Genentech USA, Inc.
$10,795
GlaxoSmithKline, LLC.
$6,815
AstraZeneca Pharmaceuticals LP
$6,205
GENZYME CORPORATION
$4,532
Pharming Healthcare, Inc.
$125
Regeneron Pharmaceuticals, Inc.
$87
Novartis Pharmaceuticals Corporation
$84
LEO Pharma Inc.
$69
kaleo, Inc.
$40
Amgen Inc.
$40
Octapharma USA, Inc.
$24
Grifols USA, LLC
$23
Top 3 companies account for 73.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$235,824
Genentech USA, Inc.
$179,973
Regeneron Healthcare Solutions, Inc.
$123,943
GENZYME CORPORATION
$62,125
Boehringer Ingelheim International GmbH
$32,532
AstraZeneca Pharmaceuticals LP
$30,985
Novartis Pharmaceuticals Corporation
$19,227
Regeneron Pharmaceuticals, Inc.
$16,941
ALK-Abello, Inc
$13,698
Amgen Inc.
$12,333
OptiNose US, Inc.
$11,848
Sunovion Pharmaceuticals Inc.
$4,207
Lilly USA, LLC
$3,418
Optinose US, Inc.
$2,851
Teva Pharmaceuticals USA, Inc.
$2,495
kaleo, Inc.
$384
Genentech, Inc.
$382
Boehringer Ingelheim Pharmaceuticals, Inc.
$379
SANOFI-AVENTIS U.S. LLC
$320
PFIZER INC.
$212
Aimmune Therapeutics, Inc.
$193
Pharming Healthcare, Inc.
$164
Shire North American Group Inc
$162
Merck Sharp & Dohme LLC
$145
AIMMUNE THERAPEUTICS, INC.
$142
Kaleo, Inc.
$141
Grifols USA, LLC
$114
LEO Pharma Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$83
ABBVIE INC.
$80
BioCryst US Sales Co., LLC
$64
Mylan Specialty L.P.
$44
Octapharma USA, Inc.
$37
Eyevance Pharmaceuticals LLC
$36
USWM, LLC
$32
Merck Sharp & Dohme Corporation
$29
Phadia US Inc.
$24
Hikma Pharmaceuticals USA
$20
Aytu BioPharma, Inc.
$19
Circassia Pharmaceuticals Inc
$18
Horizon Therapeutics plc
$18
Incyte Corporation
$11
Top 3 companies account for 71.4% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ANORO · AREXVY · ASMANEX · AUVI-Q · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CINRYZE · COSENTYX · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · FIRAZYR · Flarex · GAMMAGARD · GILENYA · Gamunex-C · ImmunoCAP · LONHALA MAGNAIR · NIOX VERO · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAZEO · Prolastin-C Liquid · QVAR · RINVOQ · RUCONEST · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMJEPI · TEZSPIRE · TRELEGY ELLIPTA · Tobradex ST · UTIBRON · XOLAIR · Xembify · Xhance · Xolair · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for allergy & immunology in NY.

Looking for an allergy & immunology specialist in Rockville Centre?
Compare allergy & immunologists in the Rockville Centre area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
183
Per 100K population
13.2
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goldstein is a mixed practice specialist, with above-average Medicare volume (top 14% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goldstein experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Goldstein performed 2,411 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldstein receive payments from pharmaceutical companies?
Yes. Dr. Goldstein received a total of $755,740 from 42 companies across 1,241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldstein's costs compare to other allergy & immunologists in Rockville Centre?
Dr. Goldstein's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →